KREITZER ANATOL (Chief Discovery Officer) sold 6.8% of their position (12.25K shares) of MAPLIGHT THERAPEUTICS, INC. on the open market
Open‑market sale worth $96.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/16/2026ACC: 0002021238-26-000014
Officer· Chief Discovery Officer
Since Feb 2026
-12.25K
Net shares
Net seller
$96.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
12.25K disposed
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
−12.25K
Price / share
$7.84
Trade value
$96.02K
% of position
6.8%
10/15/2026
180.93K→168.68K
Total
Net shares
−12.25K
Net value
-$96.02K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 10/15/2026 | S · Sale | −12.25K | $7.84 | $96.02K | 6.8% | 180.93K | 168.68K |
| Total | −12.25K | -$96.02K | ||||||
Derivative Transactions0
No derivative transactions reported